Global prevalence of sexual dysfunction in cardiovascular patients: a systematic review and meta-analysis.


Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
20 May 2024
Historique:
received: 24 07 2023
accepted: 10 04 2024
medline: 21 5 2024
pubmed: 21 5 2024
entrez: 20 5 2024
Statut: epublish

Résumé

Sexual dysfunction poses a significant challenge for patients with cardiac conditions. Concerning the prevalence of sexual disorders in cardiovascular patients, several seminal studies conducted in various regions of the world have provided diverse facts and figures pertaining to sexual dysfunction among cardiovascular patients. Therefore, the present study aimed to analyze, summarize, and integrate the findings of seminal studies on the effect of underlying factors and estimate the global rate of sexual disorders in cardiovascular patients. The present systematic review and meta-analysis included studies conducted in 2003-2023. To find the relevant published academic papers, SID, MagIran, PubMed, Scopus, Web of Science (WOS), and Google Scholar databases were searched for keywords using MeSH/Emtree until January 14, 2023. The GRADEpro software was used to evaluate the quality of evidence. The heterogeneity of studies was checked using the I2 index. An initial number of 2122 studies were found in the first search. Following a precise screening process based on predefined inclusion criteria, a total of 17 studies were deemed suitable for inclusion in the meta-analysis. The global prevalence of sexual disorders in cardiovascular patients was estimated at 62.6% (95% CI: 49.8-73.8%). As the results of the meta-regression showed that as the sample size increased, there was a significant decrease in the overall prevalence of sexual disorders among cardiovascular patients. Additionally, as the study years progressed, both age and JBI score exhibited an upward trend. The present findings showed a high prevalence of sexual disorders among cardiovascular patients. Therefore, it is recommended that experts and health policymakers enhance their focus on effectively preventing and controlling these disorders. Besides the evidence achieved very low certainty, it is important for the treatment team to prioritize the sexual relations of cardiovascular patients and focus on improving their sexual function. This should be seen as an essential aspect of their overall recovery process.

Sections du résumé

BACKGROUND BACKGROUND
Sexual dysfunction poses a significant challenge for patients with cardiac conditions. Concerning the prevalence of sexual disorders in cardiovascular patients, several seminal studies conducted in various regions of the world have provided diverse facts and figures pertaining to sexual dysfunction among cardiovascular patients. Therefore, the present study aimed to analyze, summarize, and integrate the findings of seminal studies on the effect of underlying factors and estimate the global rate of sexual disorders in cardiovascular patients.
METHODS METHODS
The present systematic review and meta-analysis included studies conducted in 2003-2023. To find the relevant published academic papers, SID, MagIran, PubMed, Scopus, Web of Science (WOS), and Google Scholar databases were searched for keywords using MeSH/Emtree until January 14, 2023. The GRADEpro software was used to evaluate the quality of evidence. The heterogeneity of studies was checked using the I2 index.
RESULTS RESULTS
An initial number of 2122 studies were found in the first search. Following a precise screening process based on predefined inclusion criteria, a total of 17 studies were deemed suitable for inclusion in the meta-analysis. The global prevalence of sexual disorders in cardiovascular patients was estimated at 62.6% (95% CI: 49.8-73.8%). As the results of the meta-regression showed that as the sample size increased, there was a significant decrease in the overall prevalence of sexual disorders among cardiovascular patients. Additionally, as the study years progressed, both age and JBI score exhibited an upward trend.
CONCLUSION CONCLUSIONS
The present findings showed a high prevalence of sexual disorders among cardiovascular patients. Therefore, it is recommended that experts and health policymakers enhance their focus on effectively preventing and controlling these disorders. Besides the evidence achieved very low certainty, it is important for the treatment team to prioritize the sexual relations of cardiovascular patients and focus on improving their sexual function. This should be seen as an essential aspect of their overall recovery process.

Identifiants

pubmed: 38769586
doi: 10.1186/s13643-024-02525-0
pii: 10.1186/s13643-024-02525-0
doi:

Types de publication

Journal Article Systematic Review Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

136

Informations de copyright

© 2024. The Author(s).

Références

Park JJ, Doo SW, Kwon A, Kim DK, Yang WJ, Song YS, et al. Effects of sexual rehabilitation on sexual dysfunction in patients with cardiovascular disease: a systematic review and meta-analysis. World J Mens Health. 2023;41(2):330–41.
pubmed: 36593706 pmcid: 10042662 doi: 10.5534/wjmh.220124
Tirgari B, Rafati F, Mehdipour RR. Effect of sexual rehabilitation program on anxiety, stress, depression and sexual function among men with coronary artery disease. J Sex Marital Ther. 2019;45(7):632–42.
pubmed: 30912471 doi: 10.1080/0092623X.2019.1599091
Kouhestani HR, Baghcheghi N, Zand S. Impact of teaching cardiac rehabilitation programs on electrocardiogram changes among patients with myocardial infraction. IJNR. 2010;5:6–12.
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.
doi: 10.1016/S0140-6736(18)32203-7
Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–922.
doi: 10.1016/S0140-6736(18)32335-3
Rehan R, Kotchetkova I, Cordina R, Celermajer D. Adult congenital heart disease survivors at age 50 years: medical and psychosocial status. Heart Lung Circ. 2021;30(2):261–6.
pubmed: 32713766 doi: 10.1016/j.hlc.2020.05.114
Word Health Organization WH. Cardiovascular diseases (cvds). 2009. http://www.who.int/mediacentre/factsheets/fs317/en/index.html .
Varaei S, Shamsizadeh M, Cheraghi MA, Talebi M, Dehghani A, Abbasi A. Effects of a peer education on cardiac self-efficacy and readmissions in patients undergoing coronary artery bypass graft surgery: a randomized-controlled trial. Nurs Crit Care. 2017;22(1):19–28.
pubmed: 25349051 doi: 10.1111/nicc.12118
Nazari B, Bakhshi S, Kaboudi M, Dehghan F, Ziapour A, Montazeri N. A comparison of quality of life, anxiety and depression in children with cancer and healthy children, Kermanshah-Iran. Int J Pediatr. 2017;5(7):5305–14.
Kaboudi M, Dehghan F, Ziapour A. The effect of acceptance and commitment therapy on the mental health of women patients with type II diabetes. Ann Trop Med Public Health. 2017;10(6):1709–13.
doi: 10.4103/ATMPH.ATMPH_607_17
Soroush A, Komasi S, Heydarpour B, Ezzati P, Saeidi M. The effectiveness of psychosexual education program on psychological dimensions of sexual function and its quality in cardiac rehabilitation patients. Res Cardiovasc Med. 2018;7(2):82–6.
doi: 10.4103/rcm.rcm_5_17
Kendirci M, Nowfar S, Hellstrom W. The impact of vascular risk factors on erectile function. Drugs Today (Barcelona, Spain: 1998). 2005;41(1):65–74.
doi: 10.1358/dot.2005.41.1.875779
Palm P, Zwisler A-DO, Svendsen JH, Thygesen LC, Giraldi A, Jensen KG, et al. Sexual rehabilitation for cardiac patients with erectile dysfunction: a randomised clinical trial. Heart. 2019;105(10):775–82.
pubmed: 30381319 doi: 10.1136/heartjnl-2018-313778
Nascimento ER, Maia ACO, Pereira V, Soares-Filho G, Nardi AE, Silva AC. Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence. Clin. 2013;68:1462–8.
doi: 10.6061/clinics/2013(11)13
Johansen PP, Zwisler A-D, Hastrup-Svendsen J, Frederiksen M, Lindschou J, Winkel P, et al. The CopenHeartSF trial—comprehensive sexual rehabilitation programme for male patients with implantable cardioverter defibrillator or ischaemic heart disease and impaired sexual function: protocol of a randomised clinical trial. BMJ Open. 2013;3(11):e003967.
pubmed: 24282249 pmcid: 3845056 doi: 10.1136/bmjopen-2013-003967
Rahmanian E, Salari N, Mohammadi M, Jalali R. Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:1–17.
McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016;13(2):135–43.
pubmed: 26953828 doi: 10.1016/j.jsxm.2015.12.019
Guidelines ESoU. 2017. Available from: https://uroweb.org/guidelines/ . [cited 2018 Mar 12].
Irfan M, Hussain NHN, Noor NM, Mohamed M, Sidi H, Ismail SB. Epidemiology of male sexual dysfunction in Asian and European regions: a systematic review. Am J Mens Health. 2020;14(4):1557988320937200.
pubmed: 32623948 pmcid: 7338652 doi: 10.1177/1557988320937200
Diaconu CC, Manea M, Marcu DR, Socea B, Spinu AD, Bratu OG. The erectile dysfunction as a marker of cardiovascular disease: a review. Acta Cardiol. 2020;75(4):286–92.
pubmed: 30955454 doi: 10.1080/00015385.2019.1590498
Janjani P, Motevaseli S, Salimi Y, Bavandpouri SM, Ziapour A, Salehi N, et al. Clinical and epidemiological profile of ST-segment elevation myocardial infarction patients in a megacity of west of Iran. Health Sci Rep. 2023;6(5):e1187.
pubmed: 37152229 pmcid: 10161763 doi: 10.1002/hsr2.1187
Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294(23):2996–3002.
pubmed: 16414947 doi: 10.1001/jama.294.23.2996
Rinkūnienė E, Gimžauskaitė S, Badarienė J, Dženkevičiūtė V, Kovaitė M, Čypienė A. The prevalence of erectile dysfunction and its association with cardiovascular risk factors in patients after myocardial infarction. Medicina (Kaunas). 2021;57(10):1103.
pubmed: 34684140 doi: 10.3390/medicina57101103
Dias R, Alarcão V, da Mata S, Miranda FL, Simões R, Carreira M, et al. Erectile dysfunction in primary care: sexual health inquiry and cardiovascular risk factors among patients with no previous cardiovascular events. Rev Port Saúde Pública. 2016;34(3):250–8.
doi: 10.1016/j.rpsp.2016.06.001
Wang W, Fan J, Huang G, Zhu X, Tian Y, Tan H, et al. Meta-analysis of prevalence of erectile dysfunction in mainland China: evidence based on epidemiological surveys. Sex Med. 2017;5(1):E19–30.
pubmed: 28024996 doi: 10.1016/j.esxm.2016.10.001
Imprialos K, Koutsampasopoulos K, Manolis A, Doumas M. Erectile dysfunction as a cardiovascular risk factor: time to step up? Curr Vasc Pharmacol. 2021;19(3):301–12.
pubmed: 32286949 doi: 10.2174/1570161118666200414102556
Pfister O. Cardiovascular disease and sexuality. Ther Umsch Rev Thér. 2010;67(3):139–43.
doi: 10.1024/0040-5930/a000026
Hackett GI. Erectile dysfunction, diabetes and cardiovascular risk. Br J Diabetes. 2016;16(2):52–7.
doi: 10.15277/bjd.2016.076
Inman BA, Sauver JLS, Jacobson DJ, McGree ME, Nehra A, Lieber MM, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84:108–13. Elsevier.
pubmed: 19181643 pmcid: 2664580 doi: 10.4065/84.2.108
Lew-Starowicz Z, Czajkowska K. Prevalence of sexual dysfunctions and associated risk factors in Poland. Arch Med Sci. 2022;18(4):1031–40.
pubmed: 35832714
Mazinani R, Akbari Mehr M, Kaskian A, Kashanian M. Evaluation of prevalence of sexual dysfunctions and its related factors in women. Razi J Med Sci. 2013;19(105):59–66.
Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep. 2000;2(3):189–95.
pubmed: 11122954 doi: 10.1007/s11920-996-0006-2
Steptoe A, Jackson SE, Wardle J. Sexual activity and concerns in people with coronary heart disease from a population-based study. Heart. 2016;102(14):1095–9.
pubmed: 27126394 doi: 10.1136/heartjnl-2015-308993
Çağlar M, Yeşiltepe Oskay Ü, Arican E, Akyol E. Relationship between self-efficacy and sexual function after open heart surgery. Eur J Cardiovasc Nurs. 2021;20(4):376–82.
doi: 10.1093/eurjcn/zvaa012
Byrne M, Doherty S, McGee HM, Murphy AW. General practitioner views about discussing sexual issues with patients with coronary heart disease: a national survey in Ireland. BMC Fam Pract. 2010;11(1):1–7.
doi: 10.1186/1471-2296-11-40
Steinke EE. Sexual concerns of patients and partners after an implantable cardioverter defibrillator. Dimen Crit Care Nurs. 2003;22(2):89–96.
doi: 10.1097/00003465-200303000-00007
Liberati A, Altman D, Tetzlaff J, Mulrow C, Gøtzsche P, Ioannidis J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
pubmed: 19621070 pmcid: 2707010 doi: 10.1371/journal.pmed.1000100
Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. JBI Evid Implement. 2015;13(3):147–53.
Rajati F, Ahmadi N, Naghibzadeh ZA-S, Kazeminia M. The global prevalence of oropharyngeal dysphagia in different populations: a systematic review and meta-analysis. J Translat Med. 2022;20(1):175.
doi: 10.1186/s12967-022-03380-0
Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: a systematic review and meta-analysis. J Med Virol. 2021;93(1):257–61.
pubmed: 32603481 doi: 10.1002/jmv.26237
Heruti RJ, Steinvil A, Shochat T, Saar N, Mashav N, Arbel Y, et al. Screening for erectile dysfunction and associated cardiovascular risk factors in Israeli men. Isr Med Assoc J. 2008;10(10):686.
Schwarz ER, Kapur V, Bionat S, Rastogi S, Gupta R, Rosanio S. The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. Int J Impot Res. 2008;20(1):85–91.
pubmed: 17882230 doi: 10.1038/sj.ijir.3901613
Rusiecki L, Zdrojowy R, Gebala J, Rabijewski M, Sobieszczańska M, Smoliński R, et al. Sexual health in Polish elderly men with coronary artery disease: Importance, expectations, and reality. Asian J Androl. 2020;22(5):526–31.
pubmed: 31929194 pmcid: 7523618 doi: 10.4103/aja.aja_131_19
Fafiolu AS, Adebayo AM, Akande TO, Akinboboye OO. Erectile dysfunction among male hypertensives in a tertiary health facility in South-West Nigeria. Glob J Health Sci. 2015;7(1):154.
Mulat B, Arbel Y, Mashav N, Saar N, Steinvil A, Heruti R, et al. Depressive symptoms and erectile dysfunction in men with coronary artery disease. Urology. 2010;75(1):104–7.
pubmed: 19931891 doi: 10.1016/j.urology.2009.09.041
Fafiolu AS, Adebayo AM, Akande TO, Akinboboye OO. Erectile dysfunction among male hypertensives in a tertiary health facility in South-West Nigeria. Glob J Health Sci. 2014;7(1):154–60.
pubmed: 25560353 pmcid: 4796473 doi: 10.5539/gjhs.v7n1p154
Koh KC. Prevalence of erectile dysfunction in men with ischemic heart disease in a tertiary hospital in malaysia. Med J Malaysia. 2013;68(4):301–4.
pubmed: 24145256
Herbert K, Lopez B, Castellano J, Palacio A, Tamari L, Arcemen LM. The prevalence of erectile dysfunction in heart failure patients by race and ethnicity. Int J Impot Res. 2008;20(5):507–11.
pubmed: 18701919 doi: 10.1038/ijir.2008.35
Oshodi OY, Adeyemi JD, Oke DA, Seedat S. Sexual dysfunction among subjects with hypertension in a Nigerian teaching Hospital. Nig Q J Hosp Med. 2010;20(4):197–204.
pubmed: 21913528
Heikkilä A, Kaipia A, Venermo M, Kautiainen H, Korhonen P. Relationship of blood pressure and erectile dysfunction in men without previously diagnosed hypertension. J Sex Med. 2017;14(11):1336–41.
pubmed: 28993149 doi: 10.1016/j.jsxm.2017.09.007
Heruti RJ, Steinvil A, Shochat T, Saar N, Mashav N, Arbel Y, et al. Screening for erectile dysfunction and associated cardiovascular risk factors in Israeli men. Isr Med Assoc J. 2008;10(10):686–90.
pubmed: 19009946
Hood S, Robertson I. Erectile dysfunction: a significant health need in patients with coronary heart disease. Scott Med J. 2004;49(3):97–8.
pubmed: 15462224 doi: 10.1177/003693300404900308
Mittawae B, El-Nashaar AR, Fouda A, Magdy M, Shamloul R. Incidence of erectile dysfunction in 800 hypertensive patients: a multicenter Egyptian national study. Urology. 2006;67(3):575–8.
pubmed: 16527582 doi: 10.1016/j.urology.2005.09.040
Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol. 2003;44(3):360–4. discussion 4-5.
pubmed: 12932937 doi: 10.1016/S0302-2838(03)00305-1
Neiman A, Ginde S, Earing MG, Bartz PJ, Cohen S. The prevalence of sexual dysfunction and its association with quality of life in adults with congenital heart disease. Int J Cardiol. 2017;228:953–7.
pubmed: 27912205 doi: 10.1016/j.ijcard.2016.11.192
Ramírez R, Pedro-Botet J, García M, Corbella E, Merino J, Zambón D, et al. Erectile dysfunction and cardiovascular risk factors in a Mediterranean diet cohort. Intern Med J. 2016;46(1):52–6.
pubmed: 26482327 doi: 10.1111/imj.12937
Rinkūnienė E, Gimžauskaitė S, Badarienė J, Dženkevičiūtė V, Kovaitė M, Čypienė A. The prevalence of erectile dysfunction and its association with cardiovascular risk factors in patients after myocardial infarction. Medicina (Kaunas). 2021;57(10):1103.
Roth A, Kalter-Leibovici O, Kerbis Y, Tenenbaum-Koren E, Chen J, Sobol T, et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men. Clin Cardiol. 2003;26(1):25–30.
pubmed: 12539809 doi: 10.1002/clc.4960260106
Son YJ, Jang M, Jun EY. Prevalence of erectile dysfunction and associated factors in Korean older adults with coronary artery disease. J Gerontol Nurs. 2016;42(10):32–41.
pubmed: 27379456 doi: 10.3928/00989134-20160701-02
Ricoy-Cano AJ, Obrero-Gaitán E, Caravaca-Sánchez F, Fuente-Robles YMDL. Factors conditioning sexual behavior in older adults: a systematic review of qualitative studies. J Clin Med. 2020;9(6):1716.
pubmed: 32503157 pmcid: 7356633 doi: 10.3390/jcm9061716
Slack P, Aziz VM. Sexuality and sexual dysfunctions in older people: a forgotten problem. BJPsych Advan. 2020;26(3):173–82.
doi: 10.1192/bja.2019.80
Karami N, Kazeminia M, Karami A, Salimi Y, Ziapour A, Janjani P. Global prevalence of depression, anxiety, and stress in cardiac patients: a systematic review and meta-analysis. J Affect Disord. 2022;34:175–89.
Momeni K, Salimi Y, Majzoobi MR, Ziapour A, Janjani P. Anxiety, coping style and hopelessness during COVID-19 pandemic: an Iranian population-based study. Health Sci Rep. 2023;6(5):e1233. https://doi.org/10.1002/hsr2.1233 .
doi: 10.1002/hsr2.1233 pubmed: 37152235 pmcid: 10154849
Krzastek SC, Bopp J, Smith RP, Kovac JR. Recent advances in the understanding and management of erectile dysfunction. F1000Res. 2019;8:1–8.
doi: 10.12688/f1000research.16576.1
Rao TS, Ismail S, Darshan M, Tandon A. Sexual disorders among elderly: an epidemiological study in South Indian rural population. Indian J Psychiatry. 2015;57(3):236.
doi: 10.4103/0019-5545.166618
Shojaaldini Ardakani T, Kelimi Arli N, Pshti Amiri Banafsheh T. The elderly and sexual health (the forgotten dimension of lifestyle), the third national conference on lifestyle and health. The third national conference on lifestyle and health, Yazd. 2019. https://civilica.com/doc/1231735 .
Fisher JS, Rezk A, Nwefo E, Masterson J, Ramasamy R. Sexual health in the elderly population. Curr Sex Health Rep. 2020;12:381–8.
pubmed: 33437223 pmcid: 7799439 doi: 10.1007/s11930-020-00278-0
Salehi N, Afrashteh MY, Majzoobi MR, Ziapour A, Janjani P, Karami S. Does coping with pain help the elderly with cardiovascular disease? The association of sense of coherence, spiritual well-being and self-compassion with quality of life through the mediating role of pain self-efficacy. BMC Geriatr. 2023;23(1):393.
pubmed: 37380975 pmcid: 10304355 doi: 10.1186/s12877-023-04083-x
Durant LE, Carey MP. Self-administered questionnaires versus face-to-face interviews in assessing sexual behavior in young women. Arch Sex Behav. 2000;29:309–22.
pubmed: 10948721 doi: 10.1023/A:1001930202526
Rosen RC. Assessment of female sexual dysfunction: review of validated methods. Fertil Steril. 2002;77:89–93.
doi: 10.1016/S0015-0282(02)02966-7
Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058–72.
pubmed: 22267844 doi: 10.1161/CIR.0b013e3182447787
Hensel DJ, Nance J, Fortenberry JD. The association between sexual health and physical, mental, and social health in adolescent women. J Adolesc Health. 2016;59(4):416–21.
pubmed: 27491340 pmcid: 8596160 doi: 10.1016/j.jadohealth.2016.06.003
Steinke EE, Mosack V, Hill TJ. The influence of comorbidities, risk factors, and medications on sexual activity in individuals aged 40 to 59 years with and without cardiac conditions: US National Health and Nutrition Examination Survey, 2011 to 2012. J Cardiovasc Nurs. 2018;33(2):118–25.
pubmed: 28661990 doi: 10.1097/JCN.0000000000000433
Yilmaz BA, Sonmez Y, Sezik M. Prevalence and risk factors for sexual dysfunction in reproductive-aged married women: a cross-sectional epidemiological study. J Obst Gynaecol Res. 2020;46(3):507–16.
doi: 10.1111/jog.14185

Auteurs

Arash Ziapour (A)

Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mohsen Kazeminia (M)

Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mohammad Rouzbahani (M)

Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Saeedeh Bakhshi (S)

Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Nafiseh Montazeri (N)

Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Murat Yıldırım (M)

Department of Psychology, Faculty of Science and Letters, Agri Ibrahim Cecen University, Ağrı, Türkiye.
Graduate Studies and Research, Lebanese American University, Beirut, Lebanon.

Hani Tadbiri (H)

Islamic Azad University, Tehran Medical Branch, Tehran, Iran.

Farideh Moradi (F)

Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Parisa Janjani (P)

Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran. P_janjani@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH